Heather Bryce
Family · Huntsville, ALNPI 1982729588
Payments from drug & device makers
Across 382 payments — averaging $21.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- AstraZeneca$1K
- Bayer$730
- Lilly USA, LLC$583
- GSK$561
- Astellas Pharma US Inc$287
- plus $2K from 24 others
What the payments were for
- Food & beverage$8,071100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 133 | $1,940 |
| AstraZeneca | 50 | $1,471 |
| Bayer | 27 | $730 |
| Lilly USA, LLC | 35 | $583 |
| GSK | 26 | $561 |
| Astellas Pharma US Inc | 13 | $287 |
| Lundbeck LLC | 12 | $245 |
| Vanda Pharmaceuticals Inc. | 10 | $178 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $177 |
| SK Life Science, Inc. | 5 | $171 |
| Otsuka America Pharmaceutical, Inc. | 7 | $160 |
| Exact Sciences | 6 | $160 |
| Amarin Pharma, Inc. | 7 | $144 |
| Boehringer Ingelheim | 7 | $136 |
| Inspire Medical Systems, Inc. | 1 | $123 |
| Amgen | 7 | $122 |
| Abbott | 7 | $121 |
| Alkermes, Inc. | 1 | $118 |
| Axsome Therapeutics, Inc. | 1 | $118 |
| UCB, Inc. | 4 | $112 |
| Sanofi-aventis U.S. LLC | 4 | $84 |
| Corium, LLC | 1 | $78 |
| Sumitomo Pharma America, Inc. | 4 | $76 |
| Xeris Pharmaceuticals, Inc. | 2 | $42 |
| Neurocrine Biosciences, Inc. | 1 | $32 |
| Dexcom, Inc. | 1 | $28 |
| Shield Therapeutics Inc | 1 | $20 |
| Intra-sana Laboratories | 1 | $19 |
| Pfizer | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,072 in reported general payments places this provider in the 95th percentile of 3,415 family providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 106 | $165,956 |
| FarxigaDapagliflozin Propanediol | 76 | $78,258 |
| JardianceEmpagliflozin | 64 | $72,950 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 45 | $61,981 |
| RybelsusSemaglutide | 21 | $59,621 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 77 | $58,646 |
| MounjaroTirzepatide | 32 | $48,888 |
| JanuviaSitagliptin Phosphate | 26 | $38,892 |
| EliquisApixaban | 31 | $38,563 |
| Tresiba Flextouch U-200Insulin Degludec | 27 | $37,120 |
| VascepaIcosapent Ethyl | 31 | $23,772 |
| XareltoRivaroxaban | 26 | $21,770 |
| Trijardy XrEmpaglifloz/Linaglip/Metformin | 20 | $20,598 |
| MyrbetriqMirabegron | 15 | $17,520 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 15 | $11,914 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,940 | $225,577127 claims |
| Boehringer IngelheimJardiance, Synjardy Xr, Trijardy Xr, Synjardy | $136 | $165,245149 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,471 | $86,84589 claims |
| GSKTrelegy Ellipta | $561 | $58,64677 claims |
| Lilly USA, LLCMounjaro | $583 | $48,88832 claims |
| PfizerEliquis | $18 | $38,56331 claims |
| Astellas Pharma US IncMyrbetriq | $287 | $17,52015 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,415 family providers in Alabama.
Other family in Huntsville
- Leigh Ann ChildressHuntsville$240K
- Christina CanteyHuntsville$118K
- Julia BettsHuntsville$27K
- Joann IkardHuntsville$19K
- Hannah GarnettHuntsville$18K
- Alyssa FikesHuntsville$15K
- Justin WilsonCullman$1.1M
- Molly ReevesAuburn$158K
- Leigh LunaMontgomery$69K
- Christopher LovellMobile$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.